Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD

138.6  +0.98 (+0.71%)

After market: 138.6 0 (0%)

Fundamental Rating

7

LRN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. LRN gets an excellent profitability rating and is at the same time showing great financial health properties. LRN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make LRN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year LRN was profitable.
LRN had a positive operating cash flow in the past year.
LRN had positive earnings in each of the past 5 years.
Each year in the past 5 years LRN had a positive operating cash flow.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of LRN (13.56%) is better than 90.14% of its industry peers.
The Return On Equity of LRN (21.12%) is better than 87.32% of its industry peers.
The Return On Invested Capital of LRN (14.55%) is better than 92.96% of its industry peers.
LRN had an Average Return On Invested Capital over the past 3 years of 9.47%. This is in line with the industry average of 10.64%.
The 3 year average ROIC (9.47%) for LRN is below the current ROIC(14.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROIC 14.55%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

LRN's Profit Margin of 13.10% is amongst the best of the industry. LRN outperforms 83.10% of its industry peers.
LRN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 16.49%, LRN belongs to the top of the industry, outperforming 80.28% of the companies in the same industry.
In the last couple of years the Operating Margin of LRN has grown nicely.
The Gross Margin of LRN (39.08%) is comparable to the rest of the industry.
LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LRN is still creating some value.
LRN has more shares outstanding than it did 1 year ago.
LRN has more shares outstanding than it did 5 years ago.
LRN has a better debt/assets ratio than last year.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.36 indicates that LRN is not in any danger for bankruptcy at the moment.
LRN's Altman-Z score of 7.36 is amongst the best of the industry. LRN outperforms 87.32% of its industry peers.
The Debt to FCF ratio of LRN is 2.09, which is a good value as it means it would take LRN, 2.09 years of fcf income to pay off all of its debts.
LRN has a better Debt to FCF ratio (2.09) than 78.87% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that LRN is not too dependend on debt financing.
LRN has a Debt to Equity ratio of 0.33. This is comparable to the rest of the industry: LRN outperforms 45.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Altman-Z 7.36
ROIC/WACC1.73
WACC8.4%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

LRN has a Current Ratio of 5.61. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LRN (5.61) is better than 92.96% of its industry peers.
A Quick Ratio of 5.53 indicates that LRN has no problem at all paying its short term obligations.
LRN's Quick ratio of 5.53 is amongst the best of the industry. LRN outperforms 92.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.61
Quick Ratio 5.53
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.47%, which is quite impressive.
LRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 39.31% yearly.
The Revenue has grown by 14.90% in the past year. This is quite good.
LRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.97% yearly.
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%

3.2 Future

The Earnings Per Share is expected to grow by 21.50% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.82% on average over the next years. This is quite good.
EPS Next Y44.56%
EPS Next 2Y26.61%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue Next Year16.8%
Revenue Next 2Y12.49%
Revenue Next 3Y11.03%
Revenue Next 5Y10.82%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.62, which indicates a rather expensive current valuation of LRN.
Compared to the rest of the industry, the Price/Earnings ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 69.01% of the companies listed in the same industry.
LRN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
LRN is valuated rather expensively with a Price/Forward Earnings ratio of 18.52.
Based on the Price/Forward Earnings ratio, LRN is valued a bit cheaper than the industry average as 69.01% of the companies are valued more expensively.
LRN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.62
Fwd PE 18.52
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LRN is cheaper than 70.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LRN is valued a bit cheaper than 67.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.63
EV/EBITDA 11.49
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LRN has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LRN's earnings are expected to grow with 21.50% in the coming years.
PEG (NY)0.49
PEG (5Y)0.55
EPS Next 2Y26.61%
EPS Next 3Y21.5%

0

5. Dividend

5.1 Amount

No dividends for LRN!.
Industry RankSector Rank
Dividend Yield N/A

STRIDE INC

NYSE:LRN (7/3/2025, 7:45:17 PM)

After market: 138.6 0 (0%)

138.6

+0.98 (+0.71%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners112.37%
Inst Owner Change-2.33%
Ins Owners2.68%
Ins Owner Change-0.36%
Market Cap6.03B
Analysts83.64
Price Target165.71 (19.56%)
Short Float %9.46%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.39%
Min EPS beat(2)-0.5%
Max EPS beat(2)3.28%
EPS beat(4)3
Avg EPS beat(4)86.24%
Min EPS beat(4)-0.5%
Max EPS beat(4)331.54%
EPS beat(8)7
Avg EPS beat(8)64.82%
EPS beat(12)10
Avg EPS beat(12)21.41%
EPS beat(16)13
Avg EPS beat(16)22.68%
Revenue beat(2)2
Avg Revenue beat(2)2.53%
Min Revenue beat(2)2.13%
Max Revenue beat(2)2.93%
Revenue beat(4)4
Avg Revenue beat(4)3.46%
Min Revenue beat(4)0.58%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)3.08%
Revenue beat(12)11
Avg Revenue beat(12)3.02%
Revenue beat(16)15
Avg Revenue beat(16)3.24%
PT rev (1m)0.91%
PT rev (3m)21.24%
EPS NQ rev (1m)6.34%
EPS NQ rev (3m)7.39%
EPS NY rev (1m)1.68%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)0.76%
Revenue NQ rev (3m)3.2%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.48%
Valuation
Industry RankSector Rank
PE 21.62
Fwd PE 18.52
P/S 2.64
P/FCF 24.63
P/OCF 19.67
P/B 4.26
P/tB 6.12
EV/EBITDA 11.49
EPS(TTM)6.41
EY4.62%
EPS(NY)7.49
Fwd EY5.4%
FCF(TTM)5.63
FCFY4.06%
OCF(TTM)7.05
OCFY5.08%
SpS52.52
BVpS32.57
TBVpS22.64
PEG (NY)0.49
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 13.56%
ROE 21.12%
ROCE 19.44%
ROIC 14.55%
ROICexc 23.21%
ROICexgc 36.04%
OM 16.49%
PM (TTM) 13.1%
GM 39.08%
FCFM 10.71%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
ROICexc(3y)14.4%
ROICexc(5y)11.23%
ROICexgc(3y)26.36%
ROICexgc(5y)21.09%
ROCE(3y)12.66%
ROCE(5y)10.14%
ROICexcg growth 3Y21.6%
ROICexcg growth 5Y11.49%
ROICexc growth 3Y26.37%
ROICexc growth 5Y16.18%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
F-Score7
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.09
Debt/EBITDA 0.96
Cap/Depr 54.87%
Cap/Sales 2.7%
Interest Coverage 42.95
Cash Conversion 62.64%
Profit Quality 81.78%
Current Ratio 5.61
Quick Ratio 5.53
Altman-Z 7.36
F-Score7
WACC8.4%
ROIC/WACC1.73
Cap/Depr(3y)62.27%
Cap/Depr(5y)61.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.69%
Profit Quality(3y)114.31%
Profit Quality(5y)120.41%
High Growth Momentum
Growth
EPS 1Y (TTM)50.47%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%26.25%
EPS Next Y44.56%
EPS Next 2Y26.61%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.9%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%17.77%
Revenue Next Year16.8%
Revenue Next 2Y12.49%
Revenue Next 3Y11.03%
Revenue Next 5Y10.82%
EBIT growth 1Y63.97%
EBIT growth 3Y31.23%
EBIT growth 5Y40.56%
EBIT Next Year102.61%
EBIT Next 3Y35.59%
EBIT Next 5Y25.2%
FCF growth 1Y51.48%
FCF growth 3Y38.43%
FCF growth 5Y18.44%
OCF growth 1Y32.37%
OCF growth 3Y27.61%
OCF growth 5Y14.51%